Inventor · disambiguated record
Essa Hu Harrington
Also filed as: HARRINGTON ESSA HU
9 granted patents·3 pending applications·27 citations·filing 2009–2020
83Inventor score
Top patents by PatentIndex Score
12 records- 0190US9718803B2Unsaturated nitrogen heterocyclic compounds useful as PDE10 inhibitorsAMGEN INC·Filed 2015·Granted Aug 1, 2017·8 cites·19 claims
- 0280US9376450B2Heteroaryloxyheterocyclyl compounds as PDE10 inhibitorsAMGEN INC·Filed 2013·Granted Jun 28, 2016·4 cites·26 claims
- 0379US8497265B2Heteroaryloxyheterocyclyl compounds as PDE10 inhibitorsALLEN JENNIFER R·Filed 2011·Granted Jul 30, 2013·4 cites·16 claims
- 0479US8318718B2Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitorsALLEN JENNIFER R·Filed 2009·Granted Nov 27, 2012·4 cites·94 claims
- 0578US9174992B2Heterobicyclic compoundsAMGEN INC·Filed 2013·Granted Nov 3, 2015·4 cites·17 claims
- 0677US8637500B2Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitorsALLEN JENNIFER R·Filed 2009·Granted Jan 28, 2014·3 cites·18 claims
- 0757US2014213572A1Unsaturated nitrogen heterocyclic compounds useful as pde10 inhibitorsAMGEN INC·Filed 2014·Application pending·0 cites
- 0854US2016280703A1Heteroaryloxycarbocyclyl Compounds as PDE 10 InhibitorsAMGEN INC·Filed 2014·Application pending·0 cites
- 0950US2022340911A1Rnai constructs for inhibiting slc30a8 expression and methods of use thereofAMGEN INC·Filed 2020·Application pending·0 cites
- 1049US8759532B2Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitorsAMGEN INC·Filed 2012·Granted Jun 24, 2014·0 cites·80 claims
- 1148US11643440B2Peptide PAC1 antagonistsAMGEN INC·Filed 2018·Granted May 9, 2023·0 cites·4 claims
- 1242US9394297B2Amides as pim inhibitorsAMGEN INC·Filed 2013·Granted Jul 19, 2016·0 cites·20 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →